Thomas M, Job C K, Kurian P V
Int J Lepr Other Mycobact Dis. 1976 Jul-Sep;44(3):315-8.
The pseudocholinesterase levels and the nature of the enzyme as shown by the dibucaine number (D.N.) were estimated in 720 controls and 420 lepromatous leprosy patients, and 301 tuberculoid leprosy patients. There was no statistical difference in the esterase levels between leprosy patients and normal controls. But the distribution of D.N. was significantly different in the leprosy patients compared to the normal population studied. The D.N. below 40 indicates the samples with the atypical pseudocholinesterase--the presence of which is genetically determined. The distribution of samples with D.N. below 40 was significantly higher in the lepromatous leprosy patients compared to the normal population or tuberculoid leprosy patients. It is proposed that since there is a greater incidence of the atypical enzyme in lepromatous leprosy cases, the presence of this enzyme or the deficiency of the typical enzyme may make a person more susceptible to leprosy.
在720名对照者、420名瘤型麻风患者和301名结核样型麻风患者中,对假胆碱酯酶水平以及由地布卡因值(D.N.)所显示的酶的性质进行了评估。麻风患者和正常对照者之间的酯酶水平无统计学差异。但是,与所研究的正常人群相比,麻风患者中地布卡因值的分布存在显著差异。地布卡因值低于40表明样本中存在非典型假胆碱酯酶,其存在由基因决定。与正常人群或结核样型麻风患者相比,瘤型麻风患者中地布卡因值低于40的样本分布显著更高。有人提出,由于瘤型麻风病例中非典型酶的发生率更高,这种酶的存在或典型酶的缺乏可能使一个人更容易患麻风病。